The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 15, 2024
Filed:
Dec. 15, 2022
Applicant:
Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);
Inventors:
Kevin A. Bray, Garnerville, NY (US);
Frank Delfino, Poughquag, NY (US);
Matthew C. Franklin, Great Neck, NY (US);
Elena S. Garnova, White Plains, NY (US);
Jessica Kirshner, New York, NY (US);
Douglas MacDonald, New York, NY (US);
William Olson, Yorktown Heights, NY (US);
Gavin Thurston, Millerton, NY (US);
Assignee:
Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 39/00 (2006.01); A61P 31/20 (2006.01); A61P 35/00 (2006.01); C07K 16/08 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 39/0008 (2013.01); A61K 39/0011 (2013.01); A61P 31/20 (2018.01); A61P 35/00 (2018.01); C07K 16/084 (2013.01); C07K 16/2809 (2013.01); C07K 16/2833 (2013.01); C07K 16/2875 (2013.01); A61K 2039/545 (2013.01); A61K 2039/572 (2013.01); C07K 2317/32 (2013.01); C07K 2317/92 (2013.01);
Abstract
The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.